Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial

中国成年人注射两次未激活SARS-CoV-2型疫苗后序贯口服Ad5-nCoV雾化剂型的异种增强免疫原性和安全性研究：一项随机、开放标签的单中心试验

---

Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials

基于灭活流感病毒载体的滴鼻剂型SARS-CoV-2疫苗在成人中的安全性和免疫原性的研究：一项随机、双盲、安慰剂对照的1期和2期试验

---

Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

英国长期 COVID （冠状病毒病）炎症特征以及与住院后 1 年恢复的相关性：一项前瞻性观察性研究

---

The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial

阿奇霉素对患有囊性纤维化的结构性肺疾病婴儿（COMBAT CF）的效果：一项随机、双盲、安慰剂对照3期临床试验

---

Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial

FINLAY-FR-1A疫苗在COVID-19恢复期患者中的安全性和免疫原性的研究：开放标签2a期临床试验，和无缝衔接的双盲、随机、安慰剂对照的2b期临床试验

---

2022 update on clinical practice guidelines for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis

2022年特发性肺纤维化和进行性肺纤维化临床实践指南更新

来源公众号：重症医学动态